| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 645 |
| 1 | PREDNISONE | 472 |
| 2 | OCTREOTIDE ACETATE | 403 |
| 3 | METHOTREXATE SODIUM | 392 |
| 4 | RITUXIMAB | 365 |
| 5 | METHOTREXATE | 350 |
| 6 | DEXAMETHASONE | 345 |
| 7 | DEXAMETHASONE 1.5 MG | 345 |
| 8 | BEVACIZUMAB | 318 |
| 9 | ACETAMINOPHEN | 311 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SELUMETINIB | 27 | 0.0160 |
| 1 | PEGVISOMANT | 54 | 0.0132 |
| 2 | OCTREOTIDE ACETATE | 403 | 0.0131 |
| 3 | INAVOLISIB | 7 | 0.0104 |
| 4 | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | 4 | 0.0101 |
| 5 | PASIREOTIDE | 17 | 0.0075 |
| 6 | VEMURAFENIB | 88 | 0.0073 |
| 7 | OMEGA-3-ACID ETHYL ESTERS | 14 | 0.0072 |
| 8 | PEXIDARTINIB HYDROCHLORIDE | 5 | 0.0070 |
| 9 | RIBOCICLIB | 218 | 0.0067 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1090 |
| 1 | Kinase Inhibitor [EPC] | 806 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 724 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 628 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 449 |
| 5 | Benzodiazepine [EPC] | 443 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 391 |
| 7 | Thalidomide Analog [EPC] | 391 |
| 8 | Alkylating Drug [EPC] | 380 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 361 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Catecholamine Synthesis Inhibitor [EPC] | 1 | 0.0123 |
| 1 | Ergot Derivative [EPC] | 27 | 0.0055 |
| 2 | Somatostatin Analog [EPC] | 34 | 0.0049 |
| 3 | Hedgehog Pathway Inhibitor [EPC] | 36 | 0.0038 |
| 4 | Estrogen Receptor Antagonist [EPC] | 146 | 0.0036 |
| 5 | Anthracycline Topoisomerase Inhibitor [EPC] | 7 | 0.0029 |
| 6 | Vitamin B6 Analog [EPC] | 1 | 0.0028 |
| 7 | Cortisol Synthesis Inhibitor [EPC] | 2 | 0.0026 |
| 8 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 55 | 0.0026 |
| 9 | Vitamin D2 Analog [EPC] | 18 | 0.0025 |